Investor Presentation
Filed with ASX · · 21 pages · English
Summary by 6ix AI
This filing is an investor presentation by Patrys Limited regarding the acquisition of Reliis and its strategic plans. The presentation also discusses the board of directors and their qualifications, emphasizing the team's experience in the biotech sector. Additionally, it includes a safe harbour statement regarding investment risks associated with Patrys Limited.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Earlier from Patrys
- Completion of Acquisition and Board Appointments
- Pipeline Expanded with Proprietary Injectable Antipsychotic
- Trading Halt
- Appendix 4C - Quarterly - 30 September 2025
- Patrys Receives R&D Tax Incentive Refund
Later from Patrys
- Appendix 4C - Quarterly - 31 December 2025
- Appointment of Chief Executive Officer
- Appendix 4D - Half Year Accounts - 31 December 2025
- RLS-2201 Manufacturing and Regulatory Pathway Initiated
- Investor Presentation - Broker Meets Biotech
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys